Although many mechanisms may result in impaired CD8 T-cell responses in large tumors (systemic immunosuppression, poor intratumoral vascularity, rapid tumor growth kinetics), we chose to focus on tumor associated immunosuppression (MDSCs). The gene discussed is CD8A; the disease is neoplasm.